Abstract Cancer stem cells (CSCs) are a subpopulation of cells within tumors that possess the stem cell characteristics of self‐renewal, quiescence, differentiation, and the ability to recapitulate the parental tumor when transplanted into a host. CSCs are correlated with poor clinical outcome due to their contribution to chemotherapy resistance and metastasis. Multiple cell surface and enzymatic markers have been characterized to identify CSCs within a heterogeneous tumor, and here we summarize ongoing preclinical and clinical efforts to therapeutically target these cells and improve patient outcomes. Stem Cells Translational Medicine 2019;8:75–8
Cancer stem cells (CSCs) are self-renewable cell types that are identified in most types of liquid a...
Different mechanisms contribute to intratumor heterogeneity, including genetic mutations, the microe...
The major goal of researchers and oncologists is to develop promising ground for novel therapeutic s...
Surgery, radiotherapy and chemotherapy are universally recognized as the most effective anti-cancer ...
Cancer stem cells (CSCs) are the pathological counterpart of normal somatic tissue stem cells. They ...
Introduction: Several reports have suggested that a population of undifferentiated cells known as ca...
Cancer stem cells (CSCs) are gaining prominence in oncology. The characterization of the molecular p...
Cancer stem cells (CSCs), also known as tumor-initiating cells (TICs), are elucidated as cells that ...
Resistance to chemotherapy and cancer relapse are major clinical challenges attributed to a sub popu...
Since their description and identification in leukemias and solid tumors, cancer stem cells (CSC) ha...
Cancer stem cells (CSCs) have been demonstrated in a variety of tumors and are thought to act as a c...
The test for the cancer stem cell (CSC) hypothesis is to find a target expressed on all, and only CS...
Increasing evidence suggests that cancer cell populations contain a small proportion of cells that d...
The biology of cancer stem cells (CSC) has been investigated and debated for past 20 years. Owning t...
The discovery of stem cells and their potential abilities in self-renewal and differentiation has op...
Cancer stem cells (CSCs) are self-renewable cell types that are identified in most types of liquid a...
Different mechanisms contribute to intratumor heterogeneity, including genetic mutations, the microe...
The major goal of researchers and oncologists is to develop promising ground for novel therapeutic s...
Surgery, radiotherapy and chemotherapy are universally recognized as the most effective anti-cancer ...
Cancer stem cells (CSCs) are the pathological counterpart of normal somatic tissue stem cells. They ...
Introduction: Several reports have suggested that a population of undifferentiated cells known as ca...
Cancer stem cells (CSCs) are gaining prominence in oncology. The characterization of the molecular p...
Cancer stem cells (CSCs), also known as tumor-initiating cells (TICs), are elucidated as cells that ...
Resistance to chemotherapy and cancer relapse are major clinical challenges attributed to a sub popu...
Since their description and identification in leukemias and solid tumors, cancer stem cells (CSC) ha...
Cancer stem cells (CSCs) have been demonstrated in a variety of tumors and are thought to act as a c...
The test for the cancer stem cell (CSC) hypothesis is to find a target expressed on all, and only CS...
Increasing evidence suggests that cancer cell populations contain a small proportion of cells that d...
The biology of cancer stem cells (CSC) has been investigated and debated for past 20 years. Owning t...
The discovery of stem cells and their potential abilities in self-renewal and differentiation has op...
Cancer stem cells (CSCs) are self-renewable cell types that are identified in most types of liquid a...
Different mechanisms contribute to intratumor heterogeneity, including genetic mutations, the microe...
The major goal of researchers and oncologists is to develop promising ground for novel therapeutic s...